--- title: "板块更新：医疗保健类股票在周一下午出现回落" type: "News" locale: "zh-CN" url: "https://longbridge.com/zh-CN/news/277511276.md" description: "医疗股在周一下跌，纽约证券交易所医疗保健指数和 State Street 医疗保健精选行业 SPDR ETF（XLV）下跌了 1.2%。iShares 生物技术 ETF（IBB）下降了 1.1%。值得注意的是，uniQure（QURE）的股价暴跌 33%，因为 FDA 认为他们的试验数据不足以支持 AMT-130 的市场申请。Zoetis（ZTS）宣布以 1.6 亿美元收购 Neogen（NEOG）的动物基因组业务，而 Gyre Therapeutics（GYRE）的股价在达成以 3 亿美元股票收购 Cullgen 的协议后上涨了 7.4%" datetime: "2026-03-02T19:02:00.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/277511276.md) - [en](https://longbridge.com/en/news/277511276.md) - [zh-HK](https://longbridge.com/zh-HK/news/277511276.md) --- # 板块更新：医疗保健类股票在周一下午出现回落 02:02 PM EST, 03/02/2026 (MT Newswires) -- Health care stocks declined Monday afternoon with the NYSE Health Care Index and the State Street Health Care Select Sector SPDR ETF (XLV) each dropping 1.2%. The iShares Biotechnology ETF (IBB) shed 1.1%. In corporate news, uniQure (QURE) shares tumbled 33% after the US Food and Drug Administration said data from the company's Phase 1/2 trials was not sufficient to provide the primary evidence of effectiveness needed to support a marketing application for AMT-130, an investigational gene therapy for Huntington's disease. Zoetis ( ZTS ) agreed to buy Neogen's (NEOG) animal genomics business for $160 million. Neogen shares fell 0.7%, and Zoetis ( ZTS ) dropped 2%. Gyre Therapeutics ( GYRE ) shares climbed 7.4% after the company agreed to acquire clinical-stage biopharmaceutical company Cullgen for $300 million in stock. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited. ### 相关股票 - [QURE.US](https://longbridge.com/zh-CN/quote/QURE.US.md) - [ARKG.US](https://longbridge.com/zh-CN/quote/ARKG.US.md) - [XBI.US](https://longbridge.com/zh-CN/quote/XBI.US.md) - [VHT.US](https://longbridge.com/zh-CN/quote/VHT.US.md) - [PBE.US](https://longbridge.com/zh-CN/quote/PBE.US.md) - [IBB.US](https://longbridge.com/zh-CN/quote/IBB.US.md) - [IBBQ.US](https://longbridge.com/zh-CN/quote/IBBQ.US.md) - [NEOG.US](https://longbridge.com/zh-CN/quote/NEOG.US.md) - [LABD.US](https://longbridge.com/zh-CN/quote/LABD.US.md) - [IHE.US](https://longbridge.com/zh-CN/quote/IHE.US.md) - [FBT.US](https://longbridge.com/zh-CN/quote/FBT.US.md) - [BBH.US](https://longbridge.com/zh-CN/quote/BBH.US.md) - [IDNA.US](https://longbridge.com/zh-CN/quote/IDNA.US.md) - [IHI.US](https://longbridge.com/zh-CN/quote/IHI.US.md) - [GYRE.US](https://longbridge.com/zh-CN/quote/GYRE.US.md) - [XLV.US](https://longbridge.com/zh-CN/quote/XLV.US.md) - [IXJ.US](https://longbridge.com/zh-CN/quote/IXJ.US.md) - [XHE.US](https://longbridge.com/zh-CN/quote/XHE.US.md) ## 相关资讯与研究 - [纽尔真检测｜8-K：2026 财年 Q3 营收 2.11 亿美元超过预期](https://longbridge.com/zh-CN/news/282180927.md) - [全球首个 +0 毒性，异体 CAR-T 爆了](https://longbridge.com/zh-CN/news/282998855.md) - [强生公司销售额增长近 10%，上调 2026 年业绩展望](https://longbridge.com/zh-CN/news/282850988.md) - [诺和诺德携手 OpenAI 加速药物研发 旨在提升效率](https://longbridge.com/zh-CN/news/282699021.md) - [挪威主权财富基金称无意减持美国资产，仍将一半投资配置于美国](https://longbridge.com/zh-CN/news/282909039.md)